Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boland, E. A.
Right arrow Articles by Tamborlane, W. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boland, E. A.
Right arrow Articles by Tamborlane, W. V.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 22, Issue 11 1779-1784, Copyright © 1999 by American Diabetes Association

ARTICLES

Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes

EA Boland, M Grey, A Oesterle, L Fredrickson and WV Tamborlane
Yale Children's Clinical Research Center, Yale University School of Nursing, New Haven, Connecticut, USA. elizabeth.boland@yale.edu

OBJECTIVE: Recommendations from the Diabetes Control and Complications Trial (DCCT) indicate that adolescents with type 1 diabetes should be treated with intensive therapy involving multiple daily injections (MDI) of insulin or insulin pump therapy (continuous subcutaneous insulin infusion [CSII] to help obtain better metabolic control and prevent later complications. Interest has thus focused on insulin pump therapy to help adolescents meet this challenge. The purpose of this study was to examine responses to CSII and MDI in a large group of adolescents with established type 1 diabetes during a 12-month period and to determine whether either treatment regimen more favorably affected clinical and psychosocial outcomes. RESEARCH DESIGN AND METHODS: One-third of 75 youths aged 12-20 years who were candidates for intensive therapy chose CSII as their mode of treatment. Patients received intensive treatment and education as described by the DCCT investigators. Psychosocial data (e.g., quality of life, depression, self-efficacy, and coping) were collected at baseline and at 6-month intervals, and clinical data (e.g., HbA1c levels, adverse events) were collected every 4-6 weeks. RESULTS: Although both MDI- and CSII-treated adolescents initially exhibited improved metabolic control, this level of control was more difficult to sustain for 12 months in the MDI group (at 6 months HbA1c = 8.1, at 12 months HbA1c = 8.3), whereas average HbA1c levels in the CSII group continued to decrease during the 12 months of treatment (at 6 months HbA1c = 7.7, at 12 months HbA1c = 7.5). Despite lower HbA1c levels in CSII-versus MDI-treated patients, the rate of severe hypoglycemic events was reduced by almost 50% in the CSII group (P = 0.01). Self-reported questionnaires demonstrated that there was improvement in self-efficacy, depression, and quality of life in both MDI- and CSII-treated patients. Finally, adolescents using CSII found coping with diabetes to be less difficult than adolescents using MDI did. CONCLUSIONS: CSII is an alternative means to lower HbA1c levels and reduce the risk of hypoglycemia without adversely affecting psychosocial outcomes in adolescents with type 1 diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 The Diabetes EducatorHome page
C. Johns, M. S. Faulkner, and L. Quinn
Characteristics of Adolescents With Type 1 Diabetes Who Exhibit Adverse Outcomes
The Diabetes Educator, September 1, 2008; 34(5): 874 - 885.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. L. Exelbert
Safety of Insulin Pumps, Even in Adolescent Use, Depends on Thorough Patient Selection, Evaluation, and Education
Pediatrics, September 1, 2008; 122(3): 682 - 682.
[Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
M. E. Hilliard, M. Goeke-Morey, F. R. Cogen, C. Henderson, and R. Streisand
Predictors of Diabetes-related Quality of Life after Transitioning to the Insulin Pump
J. Pediatr. Psychol., June 27, 2008; (2008) jsn062v2.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. U. Cope, A. E. Morrison, and J. Samuels-Reid
Adolescent Use of Insulin and Patient-Controlled Analgesia Pump Technology: A 10-Year Food and Drug Administration Retrospective Study of Adverse Events
Pediatrics, May 1, 2008; 121(5): e1133 - e1138.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
S. W. Ponder, J. S. Skyler, D. F. Kruger, D. Matheson, and B. W. Brown
Unexplained Hyperglycemia in Continuous Subcutaneous Insulin Infusion: Evaluation and Treatment
The Diabetes Educator, March 1, 2008; 34(2): 327 - 333.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Shalitin and M. Phillip
Hypoglycemia in Type 1 Diabetes: A still unresolved problem in the era of insulin analogs and pump therapy
Diabetes Care, February 1, 2008; 31(Supplement_2): S121 - S124.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
F. R. Cogen, C. Henderson, J. A. Hansen, and R. Streisand
Pediatric Quality of Life in Transitioning to the Insulin Pump: Does Prior Regimen Make a Difference?
Clinical Pediatrics, December 1, 2007; 46(9): 777 - 779.
[Abstract] [PDF]

Home page
 The Diabetes EducatorHome page
E. B. Fisher, C. T. Thorpe, B. M. DeVellis, and R. F. DeVellis
Healthy Coping, Negative Emotions, and Diabetes Management: A Systematic Review and Appraisal
The Diabetes Educator, November 1, 2007; 33(6): 1080 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. E. de Beaufort, P. G.F. Swift, C. T. Skinner, H. J. Aanstoot, J. Aman, F. Cameron, P. Martul, F. Chiarelli, D. Daneman, T. Danne, et al.
Continuing Stability of Center Differences in Pediatric Diabetes Care: Do Advances in Diabetes Treatment Improve Outcome?: The Hvidoere Study Group on Childhood Diabetes
Diabetes Care, September 1, 2007; 30(9): 2245 - 2250.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Phillip, T. Battelino, H. Rodriguez, T. Danne, F. Kaufman, and for the Consensus forum participants
Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care, June 1, 2007; 30(6): 1653 - 1662.
[Full Text] [PDF]

Home page
 Clin. DiabetesHome page
J. S. Skyler, S. Ponder, D. F. Kruger, D. Matheson, and C. G. Parkin
Is There a Place for Insulin Pump Therapy in Your Practice?
Clin. Diabetes, April 1, 2007; 25(2): 50 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. D. Ritholz, A. Smaldone, J. Lee, A. Castillo, H. Wolpert, and K. Weinger
Perceptions of Psychosocial Factors and the Insulin Pump
Diabetes Care, March 1, 2007; 30(3): 549 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P.-M. Holterhus, R. Odendahl, S. Oesingmann, R. Lepler, V. Wagner, O. Hiort, R. Holl, and the German/Austrian DPV Initiative and the German
Classification of Distinct Baseline Insulin Infusion Patterns in Children and Adolescents With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy
Diabetes Care, March 1, 2007; 30(3): 568 - 573.
[Abstract] [Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
J. M. Valenzuela, A. M. Patino, J. McCullough, C. Ring, J. Sanchez, M. Eidson, R. Nemery, and A. M. Delamater
Insulin Pump Therapy and Health-Related Quality of Life in Children and Adolescents with Type 1 Diabetes
J. Pediatr. Psychol., July 1, 2006; 31(6): 650 - 660.
[Abstract] [Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
M. R. Battaglia, R. Alemzadeh, H. Katte, P. L. Hall, and L. C. Perlmuter
Brief Report: Disordered Eating and Psychosocial Factors in Adolescent Females with Type 1 Diabetes Mellitus
J. Pediatr. Psychol., July 1, 2006; 31(6): 552 - 556.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. Nimri, N. Weintrob, H. Benzaquen, R. Ofan, G. Fayman, and M. Phillip
Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
Pediatrics, June 1, 2006; 117(6): 2126 - 2131.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. Berhe, D. Postellon, B. Wilson, and R. Stone
Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
Pediatrics, June 1, 2006; 117(6): 2132 - 2137.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
S. Owen
Pediatric Pumps: Barriers and Breakthroughs
The Diabetes Educator, January 1, 2006; 32(1): 29S - 38S.
[Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
L. K. Fisher and M. Halvorson
Future Developments in Insulin Pump Therapy: Progression From Continuous Subcutaneous Insulin Infusion to a Sensor-Pump System
The Diabetes Educator, January 1, 2006; 32(1): 47S - 52S.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
O. Kordonouri, R. Hartmann, R. Lauterborn, C. Barnekow, J. Hoeffe, and D. Deiss
Age-Specific Advantages of Continuous Subcutaneous Insulin Infusion as Compared With Multiple Daily Injections in Pediatric Patients: One-year follow-up comparison by matched-pair analysis
Diabetes Care, January 1, 2006; 29(1): 133 - 134.
[Full Text] [PDF]

Home page
 PediatricsHome page
G. Admon, Y. Weinstein, B. Falk, N. Weintrob, H. Benzaquen, R. Ofan, G. Fayman, L. Zigel, N. Constantini, and M. Phillip
Exercise With and Without an Insulin Pump Among Children and Adolescents With Type 1 Diabetes Mellitus
Pediatrics, September 1, 2005; 116(3): e348 - e355.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
E. A. Doyle (Boland), A. T. Steffen, and W. V. Tamborlane
Case Study: Contrasting Challenges of Insulin Pump Therapy in a Toddler and Adolescent With Type 1 Diabetes
The Diabetes Educator, July 1, 2005; 31(4): 584 - 590.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. Lepore, A. R. Dodesini, I. Nosari, and R. Trevisan
Age and A1C Are Important Clinical Predictors of Continuous Subcutaneous Insulin Infusion Efficacy in Type 1 Diabetic Patients
Diabetes Care, July 1, 2005; 28(7): 1834 - 1835.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
S. A. Weinzimer, E. A. Doyle, and W. V. Tamborlane Jr
Disease Management in the Young Diabetic Patient: Glucose Monitoring, Coping Skills, and Treatment Strategies
Clinical Pediatrics, June 1, 2005; 44(5): 393 - 403.
[Abstract] [PDF]

Home page
 PediatricsHome page
R. Alemzadeh, T. Berhe, and D. T. Wyatt
Flexible Insulin Therapy With Glargine Insulin Improved Glycemic Control and Reduced Severe Hypoglycemia Among Preschool-Aged Children With Type 1 Diabetes Mellitus
Pediatrics, May 1, 2005; 115(5): 1320 - 1324.
[Abstract] [Full Text] [PDF]

Home page
 J Pediatr PsycholHome page
K. S. Berlin, D. A. Sass, W. H. Davies, S. Reupert, and A. A. Hains
Brief Report: Parent Perceptions of Hypoglycemic Symptoms of Youth With Diabetes; Disease Disclosure Minimizes Risk of Negative Evaluations
J. Pediatr. Psychol., March 1, 2005; 30(2): 207 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. M. Wilson, B. A. Buckingham, E. L. Kunselman, M. M. Sullivan, H. U. Paguntalan, and S. E. Gitelman
A Two-Center Randomized Controlled Feasibility Trial of Insulin Pump Therapy in Young Children With Diabetes
Diabetes Care, January 1, 2005; 28(1): 15 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. Siegel-Czarkowski, K. C. Herold, and R. S. Goland
Continuous Subcutaneous Insulin Infusion in Older Patients With Type 1 Diabetes
Diabetes Care, December 1, 2004; 27(12): 3022 - 3023.
[Full Text]

Home page
 PediatricsHome page
S. A. Weinzimer, J. H. Ahern, E. A. Doyle, M. R. Vincent, J. Dziura, A. T. Steffen, and W. V. Tamborlane
Persistence of Benefits of Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes: A Follow-up Report
Pediatrics, December 1, 2004; 114(6): 1601 - 1605.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. A. Doyle, S. A. Weinzimer, A. T. Steffen, J. A. H. Ahern, M. Vincent, and W. V. Tamborlane
A Randomized, Prospective Trial Comparing the Efficacy of Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections Using Insulin Glargine
Diabetes Care, July 1, 2004; 27(7): 1554 - 1558.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
N. Weintrob, A. Schechter, H. Benzaquen, S. Shalitin, P. Lilos, A. Galatzer, and M. Phillip
Glycemic Patterns Detected by Continuous Subcutaneous Glucose Sensing in Children and Adolescents With Type 1 Diabetes Mellitus Treated by Multiple Daily Injections vs Continuous Subcutaneous Insulin Infusion
Arch Pediatr Adolesc Med, July 1, 2004; 158(7): 677 - 684.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. Alemzadeh, J. N. Ellis, M. K. Holzum, E. A. Parton, and D. T. Wyatt
Beneficial Effects of Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Insulin Regimen Using Insulin Glargine in Type 1 Diabetes
Pediatrics, July 1, 2004; 114(1): e91 - e95.
[Abstract] [Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
P. Hammond
Continuous subcutaneous insulin infusion: short-term benefits apparent, long-term benefits speculative
The British Journal of Diabetes & Vascular Disease, March 1, 2004; 4(2): 104 - 108.
[Abstract] [PDF]

Home page
 Arch. Dis. Child.Home page
T Torrance, V Franklin, and S Greene
Insulin pumps
Arch. Dis. Child., November 1, 2003; 88(11): 949 - 953.
[Full Text] [PDF]

Home page
 PediatricsHome page
N. Weintrob, H. Benzaquen, A. Galatzer, S. Shalitin, L. Lazar, G. Fayman, P. Lilos, Z. Dickerman, and M. Phillip
Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Regimens in Children With Type 1 Diabetes: A Randomized Open Crossover Trial
Pediatrics, September 1, 2003; 112(3): 559 - 564.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Weissberg-Benchell, J. Antisdel-Lomaglio, and R. Seshadri
Insulin Pump Therapy: a Meta-Analysis: Response to DeVries et al.
Diabetes Care, August 1, 2003; 26(8): 2485 - 2486.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Weissberg-Benchell, J. Antisdel-Lomaglio, and R. Seshadri
Insulin Pump Therapy: A meta-analysis
Diabetes Care, April 1, 2003; 26(4): 1079 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. P. Plotnick, L. M. Clark, F. L. Brancati, and T. Erlinger
Safety and Effectiveness of Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes
Diabetes Care, April 1, 2003; 26(4): 1142 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
M. A. Wilson and C. B. Smith
Nutrient Intake, Glycemic Control, and Body Mass Index in Adolescents Using Continuous Subcutaneous Insulin Infusion and Those Using Traditional Insulin Therapy
The Diabetes Educator, March 1, 2003; 29(2): 230 - 238.
[PDF]

Home page
 Diabetes CareHome page
R. Amin, K. Ross, C. L. Acerini, J. A. Edge, J. Warner, and D. B. Dunger
Hypoglycemia Prevalence in Prepubertal Children With Type 1 Diabetes on Standard Insulin Regimen: Use of Continuous Glucose Monitoring System
Diabetes Care, March 1, 2003; 26(3): 662 - 667.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Dental AssociationHome page
J. R. KEENE, S. I. KALTMAN, and H. M. KAPLAN
Treatment of patients who have type 1 diabetes mellitus: Physiological misconceptions and infusion pump therapy
J Am Dent Assoc, August 1, 2002; 133(8): 1088 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
A. W. Norris and L. M.B. Laffel
Avoiding Nocturnal Hypoglycemia: Consideration of an Extra Injection at Bedtime
Ann Intern Med, April 2, 2002; 136(7): 547 - 549.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Pickup and H. Keen
Continuous Subcutaneous Insulin Infusion at 25 Years: Evidence base for the expanding use of insulin pump therapy in type 1 diabetes
Diabetes Care, March 1, 2002; 25(3): 593 - 598.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
M. J. Lenhard and G. D. Reeves
Continuous Subcutaneous Insulin Infusion: A Comprehensive Review of Insulin Pump Therapy
Arch Intern Med, October 22, 2001; 161(19): 2293 - 2300.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Tsui, A. Barnie, S. Ross, R. Parkes, and B. Zinman
Intensive Insulin Therapy With Insulin Lispro: A randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection
Diabetes Care, October 1, 2001; 24(10): 1722 - 1727.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. M. Delamater, A. M. Jacobson, B. Anderson, D. Cox, L. Fisher, P. Lustman, R. Rubin, and T. Wysocki
Psychosocial Therapies in Diabetes: Report of the Psychosocial Therapies Working Group
Diabetes Care, July 1, 2001; 24(7): 1286 - 1292.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
G. J. Klingensmith, R. Temple-Trujillo, and D. Johnson
Pump Therapy for Children: Weighing the Risks and Benefits: View 1: The Cons of Insulin Pump Therapy in the Young Child
Diabetes Spectr, April 1, 2001; 14(2): 81 - 83.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. K. Maniatis, G. J. Klingensmith, R. H. Slover, C. J. Mowry, and H. P. Chase
Continuous Subcutaneous Insulin Infusion Therapy for Children and Adolescents: An Option for Routine Diabetes Care
Pediatrics, February 1, 2001; 107(2): 351 - 356.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
B. W. Bode and P. Strange
Efficacy, Safety, and Pump Compatibility of Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes
Diabetes Care, January 1, 2001; 24(1): 69 - 72.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.